9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Adela, Inc
University Health Network, Toronto
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
Washington University School of Medicine
Institut Bergonié
University of Alabama at Birmingham
Tempus AI
RenJi Hospital
University Health Network, Toronto
Taproot Health
Cedars-Sinai Medical Center
Sanguine Biosciences
Celldex Therapeutics
Huashan Hospital
Corvus Pharmaceuticals, Inc.
City of Hope Medical Center
Ludwig Institute for Cancer Research
Weprom
University of South Florida
Hospices Civils de Lyon
Masonic Cancer Center, University of Minnesota
Celgene
University of Chicago
National Institutes of Health Clinical Center (CC)
Amgen
Masonic Cancer Center, University of Minnesota
Amgen
Columbia University
University of Alabama at Birmingham
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
The Cleveland Clinic
Valerio Therapeutics
Indiana University
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)